ZyVersa Therapeutics Stock Forecast - Simple Regression

ZVSADelisted Stock   0.15  0.01  7.14%   
The Simple Regression forecasted value of ZyVersa Therapeutics on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 6.69. ZyVersa Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ZyVersa Therapeutics stock prices and determine the direction of ZyVersa Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ZyVersa Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Simple Regression model is a single variable regression model that attempts to put a straight line through ZyVersa Therapeutics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

ZyVersa Therapeutics Simple Regression Price Forecast For the 26th of July

Given 90 days horizon, the Simple Regression forecasted value of ZyVersa Therapeutics on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.69.
Please note that although there have been many attempts to predict ZyVersa Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ZyVersa Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

ZyVersa Therapeutics Stock Forecast Pattern

Backtest ZyVersa TherapeuticsZyVersa Therapeutics Price PredictionBuy or Sell Advice 

ZyVersa Therapeutics Forecasted Value

In the context of forecasting ZyVersa Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ZyVersa Therapeutics' downside and upside margins for the forecasting period are 0 and 11.27, respectively. We have considered ZyVersa Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.15
0.49
Expected Value
11.27
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of ZyVersa Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent ZyVersa Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.1623
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1097
MAPEMean absolute percentage error0.3251
SAESum of the absolute errors6.6893
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as ZyVersa Therapeutics historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for ZyVersa Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ZyVersa Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ZyVersa Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.1510.92
Details
Intrinsic
Valuation
LowRealHigh
0.010.1410.91
Details

Other Forecasting Options for ZyVersa Therapeutics

For every potential investor in ZyVersa, whether a beginner or expert, ZyVersa Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ZyVersa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ZyVersa. Basic forecasting techniques help filter out the noise by identifying ZyVersa Therapeutics' price trends.

ZyVersa Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ZyVersa Therapeutics stock to make a market-neutral strategy. Peer analysis of ZyVersa Therapeutics could also be used in its relative valuation, which is a method of valuing ZyVersa Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

ZyVersa Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ZyVersa Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ZyVersa Therapeutics' current price.

ZyVersa Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how ZyVersa Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ZyVersa Therapeutics shares will generate the highest return on investment. By undertsting and applying ZyVersa Therapeutics stock market strength indicators, traders can identify ZyVersa Therapeutics entry and exit signals to maximize returns.

ZyVersa Therapeutics Risk Indicators

The analysis of ZyVersa Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ZyVersa Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zyversa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Historical Fundamental Analysis of ZyVersa Therapeutics to cross-verify your projections.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in ZyVersa Stock

If you are still planning to invest in ZyVersa Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ZyVersa Therapeutics' history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account